Viewing Study NCT07306559


Ignite Creation Date: 2026-03-26 @ 3:14 PM
Ignite Modification Date: 2026-04-12 @ 11:32 PM
Study NCT ID: NCT07306559
Status: RECRUITING
Last Update Posted: 2026-03-09
First Post: 2025-12-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
Sponsor: Boehringer Ingelheim
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Relapsed or Refractory Germ Cell Tumours View
None Advanced Relapsed or Refractory Endometrial Cancer View
None Advanced Relapsed or Refractory Ovarian Cancer View
Keywords: